Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl.
Histopathology of bone marrow (BM) biopsies plays a crucial role in the interdisciplinary approach to diagnosis and classification of chronic myeloproliferative disorders (CMPDs). Based on careful clinicopathologic studies, BM features are critical determinants that help to predict overall prognosis, to detect complications such as progression to myelofibrosis and blast crisis, and to assess therapy-related changes. A systematic evaluation of BM histopathology allows an objective identification of cases of (true) essential thrombocythemia (ET) and their separation from (false) ET, which often is the prodromal stage of chronic idiopathic myelofibrosis (CIMF). By follow-up examinations that include BM biopsies, the progression of the disease process is unveiled, which is especially important for patients with initial (early) polycythemia vera and prefibrotic CIMF that may require a different therapeutic approach than the full-blown stages. In conclusion, BM biopsy should be considered as major diagnostic tool for evaluation and follow-up of patients enrolled in prospective studies.
Thiele
J
J
Institute of Pathology, University of Cologne, Joseph-Stelzmann-Str.9, D-50924 Cologne, Germany. j.thiele@uni-koeln.de
Kvasnicka
H M
HM
Vardiman
J
J
D001853:Bone Marrow / Q000473:pathology*; D006801:Humans; D015467:Leukemia, Neutrophilic, Chronic / Q000473:pathology; D009196:Myeloproliferative Disorders / Q000175:diagnosis / Q000473:pathology*; D011087:Polycythemia Vera / Q000473:pathology; D055728:Primary Myelofibrosis / Q000473:pathology; D013920:Thrombocythemia, Essential / Q000473:pathology